Proposed Pre-clinical Alzheimers Disease diagnostic guidelines present ethical and policy challenges

Proposed Pre-clinical Alzheimers Disease diagnostic guidelines present ethical and policy challenges

The changing definitions of Alzheimer's diagnosis present new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?

In an essay in the October 11th print edition of Neurology, Jason Karlawish tackles the ethical and logistical challenges of safely and effectively communicating a diagnosis of pre-clinical Alzheimer's disease in light of the gulf between diagnosis and treatment, and the policy challenges to translating advances in diagnosis into clinical practice.

For reports on the essay, please visit Newswise.com and the Robert Wood Johnson Foundation Human Capital website.